COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,036 Articles (22,627 medRxiv, 8,409 bioRxiv)

Most recent first Previous |  Page 596: Articles 5951-5960  | Next

Effectiveness and Duration of Protection of a Fourth Dose of COVID-19 mRNA Vaccine among Long-Term Care Residents in Ontario, Canada
Grewal, R., Nguyen, L., Buchan, S. A., Wilson, S. E., Costa, A. P., Kwong, J. C.
10.1101/2022.09.29.22280526 — Posted: 2022-09-30
A simple non-invasive C reactive protein-based score can predict outcome in patients with COVID-19
Scotto, R., Lanzardo, A., Buonomo, A. R., Pinchera, B., Cattaneo, L., Sardanelli, A., Mercinelli, S., Viceconte, G., Zappulo, E., Villari, R., Foggia, M., Gentile, I., Federico II COVID-team
10.1101/2022.09.29.22280522 — Posted: 2022-09-30
When Case Reporting Becomes Untenable: Can Sewer Networks Tell Us Where COVID-19 Transmission Occurs?
Wang, Y., Liu, P., VanTassell, J., Hilton, S. P., Guo, L., Sablon, O., Wolfe, M. K., Freeman, L., Rose, W., Holt, C., Browning, M., Bryan, M., Waller, L. A., Teunis, P. F. M., Moe, C. L.
10.1101/2022.09.29.22280508 — Posted: 2022-09-30
Sensitivity of diffusion-tensor and correlated diffusion imaging to white-matter microstructural abnormalities: application in COVID-19
Teller, N., Chad, J. A., Wong, A., Gunraj, H., Ji, X., MacIntosh, B. J., Roudaia, E., Gilboa, A., Lam, B., Sekuler, A., Heyn, C., Graham, S., Black, S., Chen, J. J.
10.1101/2022.09.29.510004 — Posted: 2022-09-29
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets
Martins, M., do Nascimento, G. M., Conforti, A., Noll, J. C. G., Impellizeri, J. A., Sanches, E., Wagner, B., Lione, L., Salvatori, E., Pinto, E., Compagnone, M., Viscount, B., Hayward, J., Shorrock, C., Aurisicchio, L., Diel, D. G.
10.1101/2022.09.29.510112 — Posted: 2022-09-29
Pronounced State Level Disparities in Medicaid Prescribing of Buprenorphine for Opioid Use Disorder (2019-2020)
Dana, S. R., Nichols, S. D., McCall, K. L., Piper, B. J.
10.1101/2022.09.28.22280256 — Posted: 2022-09-29
Superposition of Droplet and Aerosol risk in the transmission of SARS-CoV-2
McCarthy, J., Dewitt, B. D., Dumas, B. A., Bennett, J. S.
10.1101/2022.09.28.22280473 — Posted: 2022-09-29
Characterizing Longitudinal Antibody Responses in Recovered Individuals Following COVID-19 Infection and Single-Dose Vaccination in British Columbia, Canada: a Prospective Cohort Study
Olmstead, A. D., Nikiforuk, A. M., Schwartz, S., Marquez, A. C., Valadbeigy, T., Flores, E., Saran, M., Goldfarb, D. M., Hayden, A., Masud, S., Jassem, A. N., Morshed, M., Sekirov, I.
10.1101/2022.09.28.22280429 — Posted: 2022-09-29
Binding and neutralizing IgG responses to SARS-CoV-2 after natural infection or vaccination
Olds, K. M., Humphreys, D. P., Gavin, K. M., Wyllie, A. L., Bauer, T. A.
10.1101/2022.09.28.22280476 — Posted: 2022-09-29
Trend and co-occurrence network study of symptoms through social media: an example of COVID-19
Wu, J., Wang, L., Hua, Y., Li, M., Zhou, L., Bates, D. W., Yang, J.
10.1101/2022.09.28.22280462 — Posted: 2022-09-29

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).